Feb 9 (Reuters)-
RaQualia Pharma Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2017 Dec 31, 2016 Dec 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.36 705 mln 1.37
(+93.2 pct) (+384.7 pct) (+0.5 pct)
Operating loss 114 mln loss 759 mln loss 618 mln
Recurring loss 44 mln loss 720 mln loss 600 mln
Net loss 27 mln loss 728 mln loss 606 mln
EPS loss 1.42 yen loss 38.80 yen loss 29.89 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))